13F-HR filed by EQT Fund Management S.a r.l.
EQT Fund Management S.a r.l. filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 5 holding rows worth $1,020,749,006.
- Accession
- 0001193125-26-224227
- Filer
- CIK 1834239
- Filed
- 2026-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 5 entries on the cover page, a total value of $1,020,749,006 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,020,749,006 with VALUE read as dollars as filed, 13F file number 028-22572. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WAYSTAR HLDG CORP | 946784105 | COM | 24,879,437 | $599,843,226 | dollars as filed | |
| OCULIS HOLDING AG | H5870P102 | CMN | 5,900,294 | $156,888,817 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 4,929,633 | $113,332,263 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 3,424,609 | $96,745,204 | dollars as filed | |
| AGOMAB THERAPEUTICS NV | 00860C102 | SPONSORED ADS | 5,141,992 | $53,939,496 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-224227 | this filing | 2026-05-14 | acceptance time not in the bulk data set |